ClinicalTrials.gg
RecruitingNCT07237191Updated Sep 30, 2026

Geriatric Distal Femur

An interventional study of Single Implant Fixation and Dual Implant Fixation in Articular Fractures, sponsored by Wake Forest University Health Sciences. Recruiting at 1 site in United States. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Updated Sep 30, 2026Study contact changedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
256
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Femoral Fractures, Distal with a site in United States — 6 open to participants now, 6 under way, none of them phase 3. Femoral Fractures, Distal · United States.

Planned enrollment
Largest of 10
256 · median 91
Started
2026
with 1 other
No phase
9 of 15
6 open now
Registered
14th of 15
by date
Lead sponsor
2 of 15
Wake Forest University Health Sciences

Among the 15 studies in Femoral Fractures, Distal with a site in United States, this one has the largest planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2026, is one of 9 with no phase, and was the 14th registered.

Femoral Fractures, Distal

31 studies on the registry are indexed under Femoral Fractures, Distal; 11 are open to participants now.

Browse Femoral Fractures, Distal studies →

Open to participants now

6 of the 15 studies in Femoral Fractures, Distal with a site in United States are open now. Recruiting first, the newest first:

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 9 Femoral Fractures, Distal studies recruiting now, 6 set no upper age limit and none stop at 75 or younger; none take children under 18; none take healthy volunteers.

This study: 55 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Femoral Fractures, Distal with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare two types of surgical fixation in patients with specific kinds of distal femur fractures. The main questions it aims to answer is which operation for distal femur fractures is better for efficient return to work and everyday activities.

Read the detailed description

Fractures of the distal femur are severe and common injuries sustained by older adults. Despite advances in implant technology, these injuries continue to have an unacceptably high rate of nonunion (failure to heal) of approximately 20%. This adverse outcome requires additional surgery to achieve fracture healing, which prolongs recovery and further delays return to activities of daily living and impacts quality of life. Despite numerous studies of a variety of different surgical treatment strategies, the incidence of nonunion remains high. Therefore, any novel strategy to reduce the risk of nonunion and accelerate return to activities after distal femur fracture warrants rigorous study. The goal of this study is to investigate a potential treatment for distal femur fractures that has the potential to improve the likelihood of fracture healing and accelerate return of patient function during the healing process.

03

Conditions studied

  • Articular Fractures

Keywords

  • distal femur fractures
  • single implant fixation
  • dual implant fixation
04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age greater than or equal to 55 years
  • Surgically treated displaced distal femur extra articular or complete articular fractures

Exclusion criteria

Exclusion Criteria:

  • Patients with injury features that preclude treatment with 2 implants
  • Patients unlikely to follow-up due to homelessness, or planning follow up at another institution
  • (BMI) > 40
  • Injury due to ground level fall
  • Patient that speaks neither English or Spanish
  • Patients with multisystem injuries that could preclude return to work
  • \< 55 years of age
  • Prisoner
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
256 participants (estimated)

Study arms

  • Other
    Single Implant Fixation

    Single implant fixation with either a precontoured lateral locking plate or an intramedullary nail which is the current standard of care.

    Procedure: Single Implant Fixation

  • Other
    Dual Implant Fixation

    Dual implant fixation with either a lateral locking plate plus an intramedullary nail or a lateral locking plate plus a supplemental medial plate which is the current standard of care.

    Procedure: Dual Implant Fixation

Interventions

  • ProcedureSingle Implant Fixation

    Lateral precontoured 4.5 mm distal femur plate or an intramedullary nail at the surgeon's discretion. Standard-of-care techniques will be used by the surgeon for fracture reduction and implant placement.

  • ProcedureDual Implant Fixation

    Lateral precontoured distal femur plate and either (1) an intramedullary nail or (2) a medial plate. The medial plate must span the extra-articular portion of the fracture and must have stiffness of a 3.5 mm reconstruction plate, 3.5 mm limited contact dynamic compression plate, or greater.

06

What researchers measure

Primary outcomes

  1. Number of Unions

    Union, as determined by the treating surgeon, will be assessed via radiographs and documented as a dichotomous outcome (yes/no), and time to union will also be captured. Nonunion will be captured via surgeon diagnosis or return to the operating room for nonunion treatment.

    Time frame: 6-week, 3, 6, 12 months

  2. Total Surgical Time - Reoperations

    The total surgical time during any reoperations will be collected from the medical record.

    Time frame: 6-week, 3, 6, 12 months

  3. Number of Reoperations

    Details regarding reoperations will also be collected, whether or not the operation results in an inpatient admission.

    Time frame: 6-week, 3, 6, 12 months

Secondary outcomes

  1. Number of Resource Utilizations

    Healthcare utilization, including all hospitalizations, emergency department visits, clinic visits, imaging, and physical therapy sessions after the index stay following injury will be documented at all follow-up visits.

    Time frame: 6-week, 3, 6, 12 month

  2. Return to Work - International Physical Activity Questionnaire (IPAQ) Scores

    Completion of the International Physical Activity Questionnaire (IPAQ). The IPAQ is a validated, self-report measure that captures detailed information about participation in a wide range of physical activities, including the number of days and amount of time spent in the previous 7 days. Responses for each type of physical activity are then transformed into the number of Metabolic Equivalent for Tasks (METs), and a METs/week is calculated for each patient. To get a continuous variable score from the IPAQ (MET minutes a week) it is considered walking to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS. Higher scores meaning more activity.

    Time frame: Week 6

  3. Return to Work - International Physical Activity Questionnaire (IPAQ) Scores

    Completion of the International Physical Activity Questionnaire (IPAQ). The IPAQ is a validated, self-report measure that captures detailed information about participation in a wide range of physical activities, including the number of days and amount of time spent in the previous 7 days. Responses for each type of physical activity are then transformed into the number of Metabolic Equivalent for Tasks (METs), and a METs/week is calculated for each patient. To get a continuous variable score from the IPAQ (MET minutes a week) it is considered walking to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS. Higher scores meaning more activity.

    Time frame: Month 3

  4. Return to Work - International Physical Activity Questionnaire (IPAQ) Scores

    Completion of the International Physical Activity Questionnaire (IPAQ). The IPAQ is a validated, self-report measure that captures detailed information about participation in a wide range of physical activities, including the number of days and amount of time spent in the previous 7 days. Responses for each type of physical activity are then transformed into the number of Metabolic Equivalent for Tasks (METs), and a METs/week is calculated for each patient. To get a continuous variable score from the IPAQ (MET minutes a week) it is considered walking to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS. Higher scores meaning more activity.

    Time frame: Month 6

  5. Return to Work - International Physical Activity Questionnaire (IPAQ) Scores

    Completion of the International Physical Activity Questionnaire (IPAQ). The IPAQ is a validated, self-report measure that captures detailed information about participation in a wide range of physical activities, including the number of days and amount of time spent in the previous 7 days. Responses for each type of physical activity are then transformed into the number of Metabolic Equivalent for Tasks (METs), and a METs/week is calculated for each patient. To get a continuous variable score from the IPAQ (MET minutes a week) it is considered walking to be 3.3 METS, moderate physical activity to be 4 METS and vigorous physical activity to be 8 METS. Higher scores meaning more activity.

    Time frame: Month 12

  6. Time to Walking Without an Assistive Device

    Use of an assistive device will be abstracted from the medical record and/or collected via patient interview at each follow up time point.

    Time frame: 6-week, 3, 6, 12 months

  7. Prescribed Weight Bearing Status

    The prescribed weightbearing status will be captured from discharge instructions and clinic notes.

    Time frame: 6-week, 3, 6, 12 months

  8. Fear of Movement -Tampa Scale for Kinesiophobia (TSK) Scores

    Tampa Scale for Kinesiophobia (TSK) will be utilized to measure fear of movement. This scale is 17 items and uses a 4-point Likert scale ranging from 'strongly disagree' to 'strongly agree'. The TSK is a validated measure for surgical and musculoskeletal patients. The 17 item TSK total scores range from 17 to 68 where the lowest 17 means no or negligible kinesiophobia, and the higher scores indicate an increasing degree of kinesiophobia.

    Time frame: 6-week, 3, 6, 12 months

  9. Health Related Quality of Life - Patient-Reported Outcomes Measurement Information System (PROMIS) Scores

    The PROMIS-29 includes seven domains: depression, anxiety, physical function, pain interference, fatigue, sleep disturbance, and ability to participate in social roles and activities. A 5-point Likert scale is used for each question and norm-based total scores (range 0-100) have been calculated so that 50 represents the mean and one standard deviation is 10 points. Higher scores represent better function.

    Time frame: 6-week, 3, 6, 12 months

  10. Global Health Status - Veterans RAND 12 Item Health Survey (VR12) Scores

    The VR-12 is a measure of global health that corresponds to seven domains: general health, physical functioning, role limitations, pain, fatigue, social functioning, and mental health. Scores range from 0 to 100. 0 indicates the lowest level of health and 100 indicates the highest level of health.

    Time frame: 6-week, 3, 6, 12 months

  11. Work Productivity and Activity Impairment Questionnaire Scores

    The Work Productivity and Activity Impairment Questionnaire (WPAI) questionnaire is an instrument to measure impairments in both paid work and unpaid work. It measures absenteeism, presenteeism as well as the impairments in unpaid activity because of health problem during the past seven days. WPAI outcomes are expressed as impairment percentages, with higher numbers indicating greater impairment and less productivity.

    Time frame: 6-week, 3, 6, 12 months

  12. Numeric Pain Rating

    Patients will be asked to rate their current pain on a visual analog scale. In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10, 0 and 20 or 0 and 100 that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.

    Time frame: 6-week, 3, 6, 12 months

  13. Pain Inventory (BPI)

    Pain will be assessed using the Brief Pain Inventory (BPI). The BPI is a commonly used and validated 15-item measure of pain intensity and interference with daily life. The BPI measures how much pain has interfered with seven daily activities, including general activity, walking, work, mood, enjoyment of life, relations with others, and sleep. BPI pain interference is typically scored as the mean of the seven interference items. Pain Score: 1 - 4 = Mild Pain. Worst Pain Score: 5 - 6 = Moderate Pain. Worst Pain Score: 7 - 10 = Severe Pain. Higher scores meaning higher pain.

    Time frame: 6-week, 3, 6, 12 months

  14. Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Subscale--Pain Interference

    The PROMIS-29 scales will be scored using a T-score metric method. A score of 50 points represents the population average for each scale, and 10 points represent one standard deviation - scores (range 0-100). Higher scores means a higher level of pain interference.

    Time frame: 6-week, 3, 6, 12 months

  15. Presence of Post-Traumatic Arthritis (PTOA) - Kellgren Lawrence (KL) Classification

    If PTOA is present, Kellgren Lawrence (KL) classification will be assessed by the panel of reviewers and documented. Higher scores represent worse PTOA. Grade 0 - Normal articular cartilage. Grade I - Softening and swelling. Grade II - Fragmentation and fissuring of less than 0.5 inches. Grade III - Fragmentation and fissuring of greater than 0.5 inches. Grade IV - Erosion down to the subchondral bone.

    Time frame: 1 year

  16. Presence of Post-Traumatic Arthritis (PTOA) - Paley Grading System (PGS)

    If PTOA is present, the Paley Grading System (PGS) will be assessed by the panel of reviewers and documented. Higher scores represent worse PTOA. Standard joint space with no evidence of degeneration was set as Grade 0. Normal joint space with the occurrence of osteophytes, subchondral sclerosis, and cysts was set as Grade 1. Joint space narrowing was set as Grade 2. Disappeared joint space was set as Grade 3.

    Time frame: 1 year

  17. Geriatric Depression Scale

    This scale has been validated in many studies and is unique in that it is tailored to a geriatric population by distinguishing between undiagnosed dementia and depression. Patients will also complete this scale to measure depression as part of health-related quality of life. The Geriatric Depression Scale (GDS) includes a total score range of 0 to 15. A score of 5 or more suggests depression. A score of 6 on this scale has a 94% sensitivity and 85% specificity for Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnosed depression.

    Time frame: 6-week, 3, 6, 12 months

  18. Morphine Milligram Equivalents (MME)

    To evaluate pain medication as a confounder to pain scores and complications MME will be calculated at each time point. To assess MME as a confounder, MME will be compared by treatment group at each time point.

    Time frame: 6-week, 3, 6, 12 months

  19. Total Surgical Time - Index Surgery

    The total surgical time during the index surgery will be collected from the medical record

    Time frame: Baseline

  20. Total Hospital Days

    Total hospital days, including the index hospitalization and any subsequent inpatient stays will be captured

    Time frame: Baseline, 6-week, 3, 6, 12 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2026 (actual). Primary completion is estimated for Dec 2028, 28 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2025
First posted
Nov 19, 2025
StartActual
Aug 23, 2026
Primary completionEst.
Dec 2028
CompletionEst.
Dec 2029
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Contact
Study contact's phone or email changed: l•••@wfusm.edu→l•••@advocatehealth.org. See the current contact
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Contact Study contact's phone or email changed: l•••@wfusm.edu→l•••@advocatehealth.org. See the current contact
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07237191
Responsible party
Sponsor
First posted
Nov 19, 2025
Start date
Aug 23, 2026
Primary completion
Dec 2028 (estimated)
Completion
Dec 2029 (estimated)
Last update
Sep 30, 2026

Study contacts

Laurence Kempton, M.D.
Contact
laurence.kempton@advocatehealth.org
7042553035
Laurence Kempton, M.D.
principal investigator · Wake Forest University Health Sciences

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion